Expression and purification of lacticin Q by small ubiquitin-related modifier fusion in Escherichia coli

Journal of Microbiology

Volumn 50, Issue 2, 2012, Pages 326-331

  Ma, Qingshan ^a   Yu, Zhanqiao ^a   Han, Bing ^a   Wang, Qing ^a   Zhang, Rijun ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

bacteriocin; Escherichia coli; lacticin Q; recombinant expression; small ubiquitin related modifier

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIOCIN; HYBRID PROTEIN; LACTICIN Q, LACTOCOCCUS LACTIS; SUMO PROTEIN;

ARTICLE; BACTERIUM; CHEMISTRY; DRUG EFFECT; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIOCINS; ESCHERICHIA COLI; GENE EXPRESSION; RECOMBINANT FUSION PROTEINS; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS;

ESCHERICHIA COLI;

EID: 84860376483     PISSN: 12258873     EISSN: 19763794     Source Type: Journal    
DOI: 10.1007/s12275-012-1425-x     Document Type: Article

References (22)

1. Beaulieu, L., Groleau, D., Miguez, C. B., Jetté, J. F., Aomari, H., and Subirade, M. 2005. Production of pediocin PA-1 in the methylotrophic yeast Pichia pastoris reveals unexpected inhibition of its biological activity due to the presence of collagen-like material. Protein Expr. Purif. 43, 111-125.
2. Bommarius, B., Jenssen, H., Elliott, M., Kindrachuk, J., Pasupuleti, M., Gieren, H., Jaeger, K. E., Hancock, R. E. W., and Kalman, D. 2010. Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli. Peptides31, 1957-1965.
3. Butt, T. R., Edavettal, S. C., Hall, J. P., and Mattern, M. R. 2005. SUMO fusion technology for difficult-to-express proteins. Protein Expr. Purif. 43, 1-9.
4. Čipáková, I., Hostinová, E., Gašperík, J., and Velebný, V. 2004. High-level expression and purification of a recombinant hBD-1 fused to LMM protein in Escherichia coli. Protein Expr. Purif. 37, 207-212.
5. Fujita, K., Ichimasa, S., Zendo, T., Koga, S., Yoneyama, F., Nakayama, J., and Sonomoto, K. 2007. Structural analysis and characterization of lacticin Q, a novel bacteriocin belonging to a new family of unmodified bacteriocins of Gram-positive bacteria. Appl. Environ. Microbiol. 73, 2871-2877.
6. Gillor, O. and Ghazaryan, L. 2007. Recent advances in bacteriocin application as antimicrobials. Recent Pat. Anti-Infect. Drug Discovery2, 115-122.
7. Jasniewski, J., Cailliez-Grimal, C., Gelhaye, E., and Revol-Junelles, A. M. 2008. Optimization of the production and purification processes of carnobacteriocins Cbn BM1 and Cbn B2 from Carnobacterium maltaromaticum CP5 by heterologous expression in Escherichia coli. J. Microbiol. Methods73, 41-48.
8. Lee, D. G., Park, Y., Kim, H. N., Kim, H. K., Kim, P. I., Choi, B. H., and Hahm, K.-S. 2002. Antifungal mechanism of an antimicrobial peptide, HP (2-20), derived from N-terminus of Helicobacter pylori ribosomal protein L1 against Candida albicans. Biochem. Biophys. Res. Commun. 291, 1006-1013.
9. Li, Y. 2009. Carrier proteins for fusion expression of antimicrobial peptides in Escherichia coli. Biotechnol. Appl. Biochem. 54, 1-9.
10. Li, J. F., Zhang, J., Song, R., Zhang, J. X., Shen, Y., and Zhang, S. Q. 2009. Production of a cytotoxic cationic antibacterial peptide in Escherichia coli using SUMO fusion partner. Appl. Microbiol. Biotechnol. 84, 383-388.
11. Li, J. F., Zhang, J., Zhang, Z., Ma, H. W., Zhang, J. X., and Zhang, S. Q. 2010. Production of bioactive human beta-defensin-4 in Escherichia coli using SUMO fusion partner. Protein J. 29, 314-319.
12. Morin, K. M., Arcidiacono, S., Beckwitt, R., and Mello, C. M. 2006. Recombinant expression of indolicidin concatamers in Escherichia coli. Appl. Microbiol. Biotechnol. 70, 698-704.
13. Muller, S., Hoege, C., Pyrowolakis, G., and Jentsch, S. 2001. Sumo, ubiquitin's mysterious cousin. Nat. Rev. Mol. Cell Biol. 2, 202-210.
14. Rao, X. C., Li, S., Hu, J. C., Jin, X. L., Hu, X. M., Huang, J. J., Chen, Z. J., Zhu, J. M., and Hu, F. Q. 2004. A novel carrier molecule for high-level expression of peptide antibiotics in Escherichia coli. Protein Expr. Purif. 36, 11-18.
15. Riley, M. A. and Wertz, J. E. 2002. Bacteriocin diversity: Ecological and evolutionary perspectives. Biochimie84, 357-364.
16. Schagger, H. 2006. Tricine-SDS-PAGE. Nat. Protoc. 1, 16-22.
17. Shen, Y., Ai, H. X., Song, R., Liang, Z. N., Li, J. F., and Zhang, S. Q. 2010. Expression and purification of moricin CM4 and human β-defensins 4 in Escherichia coli using a new technology. Microbiol. Res. 165, 713-718.
18. Sun, Z., Xia, Z., Bi, F., and Liu, J. N. 2008. Expression and purification of human urodilatin by small ubiquitin-related modifier fusion in Escherichia coli. Appl. Microbiol. Biotechnol. 78, 495-502.
19. Torkar, K. G. and Bogovi, M. B. 2003. Partial characterisation of bacteriocins produced by Bacillus cereus isolates from milk and milk products. Food Technol. Biotechnol. 41, 121-129.
20. Wei, Q., Kim, Y. S., Seo, J. H., Jang, W. S., Lee, I. H., and Cha, H. J. 2005. Facilitation of expression and purification of an antimicrobial peptide by fusion with baculoviral polyhedrin in Escherichia coli. Appl. Environ. Microbiol. 71, 5038-5043.
21. Xie, J., Zhang, R., Shang, C., and Guo, Y. 2009. Isolation and characterization of a bacteriocin produced by an isolated Bacillus subtilis LFB112 that exhibits antimicrobial activity against domestic animal pathogens. Afr. J. Biotechnol. 8, 5611-5619.
22. Yu, F., Wang, J., Zhang, P., Hong, Y., and Liu, W. 2010. Fusion expression of cecropin B-like antibacterial peptide in Escherichia coli and preparation of its antiserum. Biotechnol. Lett. 32, 669-673.